©2014 Baishideng Publishing Group Co.
World J Gastroenterol. May 7, 2014; 20(17): 4980-4986
Published online May 7, 2014. doi: 10.3748/wjg.v20.i17.4980
Published online May 7, 2014. doi: 10.3748/wjg.v20.i17.4980
Table 1 Demographics, decades of surveillance, and probable influence of advances in drug therapy
| Characteristics | Group 1CA/HGD | Group 2Non-CA/HGD |
| n = 68 | 20 | 48 |
| Gender (% female) | 50% | 46% |
| Age at diagnosis (yr), range | 27.3 (8-51) | 25 (6-61) |
| Disease duration (yr), range | 27.3 (12-54) | 29.6 (16-48) |
| Treatment with 6 MP/IFX | ||
| Subjects/decades of diagnosis of UC | Subjects received1 | Subjects received2 |
| 1930-1949 | 1 | 0 |
| 1950-1959 | 1 | 0 |
| 1960-1969 | 7 | 5 |
| 1970-1979 | 9 | 17 |
| 1980-1989 | 2 | 16 |
| 1990-1999 | 0 | 10 |
- Citation: Korelitz BI, Sultan K, Kothari M, Arapos L, Schneider J, Panagopoulos G. Histological healing favors lower risk of colon carcinoma in extensive ulcerative colitis. World J Gastroenterol 2014; 20(17): 4980-4986
- URL: https://www.wjgnet.com/1007-9327/full/v20/i17/4980.htm
- DOI: https://dx.doi.org/10.3748/wjg.v20.i17.4980